RISPERIDONE ASCENT risperidone 4mg film-coated tablet blister pack

Active ingredient:

risperidone, Quantity: 4 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Risperidone

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: colloidal anhydrous silica; maize starch; indigo carmine; hypromellose; magnesium stearate; quinoline yellow; microcrystalline cellulose; lactose monohydrate; titanium dioxide; macrogol 400

Administration route:

Oral

Units in package:

60 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Risperidone Ascent is indicated for the treatment of schizophrenia and related psychoses. Risperidone Ascent is indicated for the treatment of behavioural disturbances in dementia. Risperidone Ascent is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).

Product summary:

Visual Identification: Green, film-coated, oblong tablet engraved with "R", a breakline and "4" on one side and a plain face on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2012-09-26